Literature DB >> 31637103

Cell Therapeutic Strategies for Spinal Cord Injury.

Pinghui Zhou1,2, Jingjing Guan1, Panpan Xu1, Jingwen Zhao3, Changchun Zhang1, Bin Zhang1, Yingji Mao1,4, Wenguo Cui3.   

Abstract

Significance: Spinal cord injury (SCI) is a neurological disorder that resulted from destroyed long axis of spinal cord, affecting thousands of people every year. With the occurrence of SCI, the lesions can form cystic cavities and produce glial scar, myelin inhibitor, and inflammation that negatively impact repair of spinal cord. Therefore, SCI remains a difficult problem to overcome with present therapeutics. This review of cell therapeutics in SCI provides a systematic review of combinatory therapeutics of SCI and helps the realization of regeneration of spinal cord in the future. Recent Advances: With major breakthroughs in neurobiology in recent years, present therapeutic strategies for SCI mainly aim at nerve regeneration or neuroprotection. For nerve regeneration, the application approaches are tissue engineering and cell transplantation, while drug therapeutics is applied for neuroprotection. Cell therapeutics is a new approach that treats SCI by cell transplantation. Cell therapeutics possesses advantages of neuroprotection, immune regulation, axonal regeneration, neuron relay formation, and remyelination. Critical Issues: Neurons cannot regenerate at the site of injury. Therefore, it is essential to find a repair strategy for remyelination, axon regeneration, and functional recovery. Cell therapeutics is emerging as the most promising approach for treating SCI. Future Directions: The future application of SCI therapy in clinical practice may require a combination of multiple strategies. A comprehensive treatment of injury of spinal cord is the focus of the present research. With the combination of different cell therapy strategies, future experiments will achieve more dramatic success in spinal cord repair. Copyright 2019, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  anatomical structure; cell therapeutics; neurotrophic factors; regeneration; spinal cord injury

Year:  2019        PMID: 31637103      PMCID: PMC6798812          DOI: 10.1089/wound.2019.1046

Source DB:  PubMed          Journal:  Adv Wound Care (New Rochelle)        ISSN: 2162-1918            Impact factor:   4.730


  129 in total

1.  Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage.

Authors:  Christian Schachtrup; Jae K Ryu; Matthew J Helmrick; Eirini Vagena; Dennis K Galanakis; Jay L Degen; Richard U Margolis; Katerina Akassoglou
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

2.  Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord.

Authors:  Kristina A Kigerl; John C Gensel; Daniel P Ankeny; Jessica K Alexander; Dustin J Donnelly; Phillip G Popovich
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

3.  Exosomes Derived from Bone Mesenchymal Stem Cells Repair Traumatic Spinal Cord Injury by Suppressing the Activation of A1 Neurotoxic Reactive Astrocytes.

Authors:  Wei Liu; Yongxiang Wang; Fangyi Gong; Yuluo Rong; Yongjun Luo; Pengyu Tang; Zheng Zhou; Zhimin Zhou; Tao Xu; Tao Jiang; Siting Yang; Guoyong Yin; Jian Chen; Jin Fan; Weihua Cai
Journal:  J Neurotrauma       Date:  2018-08-13       Impact factor: 5.269

4.  Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family.

Authors:  A Hohn; J Leibrock; K Bailey; Y A Barde
Journal:  Nature       Date:  1990-03-22       Impact factor: 49.962

5.  Immediate recovery from spinal cord injury through molecular repair of nerve membranes with polyethylene glycol.

Authors:  R B Borgens; R Shi
Journal:  FASEB J       Date:  2000-01       Impact factor: 5.191

6.  A combination of GDNF and hUCMSC transplantation loaded on SF/AGs composite scaffolds for spinal cord injury repair.

Authors:  Genlong Jiao; Guofeng Lou; Yunfei Mo; Yongqin Pan; Ziyong Zhang; Rui Guo; Zhizhong Li
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-12-09       Impact factor: 7.328

7.  Local and remote growth factor effects after primate spinal cord injury.

Authors:  John H Brock; Ephron S Rosenzweig; Armin Blesch; Rod Moseanko; Leif A Havton; V Reggie Edgerton; Mark H Tuszynski
Journal:  J Neurosci       Date:  2010-07-21       Impact factor: 6.167

8.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

9.  Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors.

Authors:  Angelo H All; Payam Gharibani; Siddharth Gupta; Faith A Bazley; Nikta Pashai; Bin-Kuan Chou; Sandeep Shah; Linda M Resar; Linzhao Cheng; John D Gearhart; Candace L Kerr
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

10.  Peripheral Nerve Transplantation Combined with Acidic Fibroblast Growth Factor and Chondroitinase Induces Regeneration and Improves Urinary Function in Complete Spinal Cord Transected Adult Mice.

Authors:  Marc A DePaul; Ching-Yi Lin; Jerry Silver; Yu-Shang Lee
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240

View more
  6 in total

1.  Novel Methods of Necroptosis Inhibition for Spinal Cord Injury Using Translational Research to Limit Secondary Injury and Enhance Endogenous Repair and Regeneration.

Authors:  Brian Fiani; Athanasios Kondilis; Marisol Soula; Anthony Tao; Mohammed Ali Alvi
Journal:  Neurospine       Date:  2021-01-22

2.  The promoting effects of activated olfactory ensheathing cells on angiogenesis after spinal cord injury through the PI3K/Akt pathway.

Authors:  Xiaohui Wang; Chao Jiang; Yongyuan Zhang; Zhe Chen; Hong Fan; Yuyang Zhang; Zhiyuan Wang; Fang Tian; Jing Li; Hao Yang; Dingjun Hao
Journal:  Cell Biosci       Date:  2022-03-04       Impact factor: 7.133

Review 3.  Mechanisms of ginsenosides exert neuroprotective effects on spinal cord injury: A promising traditional Chinese medicine.

Authors:  Le Qi; Jun Zhang; Jinghong Wang; Junyan An; Wu Xue; Qinyi Liu; Yan Zhang
Journal:  Front Neurosci       Date:  2022-08-23       Impact factor: 5.152

Review 4.  Strategies and prospects of effective neural circuits reconstruction after spinal cord injury.

Authors:  Biao Yang; Feng Zhang; Feng Cheng; Liwei Ying; Chenggui Wang; Kesi Shi; Jingkai Wang; Kaishun Xia; Zhe Gong; Xianpeng Huang; Cao Yu; Fangcai Li; Chengzhen Liang; Qixin Chen
Journal:  Cell Death Dis       Date:  2020-06-08       Impact factor: 8.469

Review 5.  Nanostructured Materials for Artificial Tissue Replacements.

Authors:  Jana Pryjmaková; Markéta Kaimlová; Tomáš Hubáček; Václav Švorčík; Jakub Siegel
Journal:  Int J Mol Sci       Date:  2020-04-05       Impact factor: 5.923

6.  miR-21a-5p Promotes Inflammation following Traumatic Spinal Cord Injury through Upregulation of Neurotoxic Reactive Astrocyte (A1) Polarization by Inhibiting the CNTF/STAT3/Nkrf Pathway.

Authors:  Yining Zhang; Tingting Meng; Jianan Chen; Ying Zhang; Jianning Kang; Xinyu Li; Guilian Yu; Lige Tian; Zhengxin Jin; Hui Dong; Xiaodi Zhang; Bin Ning
Journal:  Int J Biol Sci       Date:  2021-07-05       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.